MKMonia Ben Khaled

Monia Ben Khaled

*This is an algorithmically generated author record based on publicly available information.

Monia Ben Khaled has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Partial Red Cell Exchange in the Secondary Prevention of Stroke in Sickle Cell Disease: A Prospective Study

    by Mellouli Fethi, Bouzidi Leyla, Ksouri Habib, Ben Fraj Ilhem, Rekaya Samya, Ben Khaled Monia, Kouki Ridha, Zouari Bechir, Ouederni Monia, Bejaoui Mohamed

    Introduction: Stroke is a severe complication associated with sickle cell disease (SCD). The risk of recurrence is extremely high. The present study aimed to assess the clinical and biological efficacy of Partial Red Cell Exchange (PRE) in secondary stroke prevention among a cohort of Tunisian patients with SCD. Patients and Methods: We conducted a prospective study over a 15‐year period (January 1, 2010—December 31, 2024). A total of 29 patients with sickle cell syndromes complicated by one or more strokes were enrolled. They underwent 1732 PRE. Results: The median age was 99 months (75–133). The median follow‐up duration was 78 months (49–126). The mean HbS decreased from 40.1% ± 14.1% to 21.1% ± 11.1% post‐exchange ( p < 0.0001). Treatment failure was observed in 8 of 29 patients (27.5%), with a total of 12 neurological events over a cumulative treatment duration of 1570 months. 11 of 12 recurrences (91.7%) occurred within the first 4 years of the exchange program. The presence of moyamoya vasculopathy was predictive of therapeutic failure. Conclusions: PRE remains an effective modality for secondary stroke prevention in patients with sickle cell disease. Stroke recurrences occur predominantly within the first 4 years of treatment and are more frequent in the context of severe cerebrovascular disease.

  • Open Access

    Chronic granulomatous disease: A multicenter study from the MENA region

    by Salem Al-Tamemi, Najla Mekki, Fatima Ailal, Raed Alzyoud, Waleed Al-Herz, Maryam Al-Nesf, Nesrine Radwan, Iman Nasr, Musab Al Jabri, Thouraya Kammoun, et al.

    Al-Tamemi et al. describe that autosomal recessive CGD represents a significant disease in the MENA region associated with significant morbidity and mortality. Regional challenges are related to universal newborn BCG vaccine, lack of newborn screening programs, and limitation of curative interventions such as hematopoietic stem cell transplantation and gene therapy.

  • Open Access

    Predictive factors for severity and poor treatment response in children with Evans syndrome: A retrospective cohort study

    by Monia Ben Khaled, Marwa Ben Ayed, Zaid Zaroui, Ilhem Ben Fraj, Samia Rekaya, Najla Mekki, Yosra Chebbi, Aicha Ben Taieb, Amani Merdassi, Ikram Zaiter, et al.

    Evans syndrome (ES) is a rare disorder characterized by autoimmune cytopenias affecting multiple blood cell lineages. In children, management remains particularly challenging due to the absence of clear guidelines for acute treatment and escalation to second-line therapies. We conducted a retrospective, longitudinal study (2010-2024) including pediatric patients (-3 ), splenomegaly (p=0.02), and hepatomegaly (p=0.05). Pediatric ES is therefore a severe condition particularly in infants. Outcomes are strongly influenced by underlying immune dysregulation, highlighting the need for early etiological evaluation to guide timely and appropriate therapeutic strategies including the early use of targeted or curative approaches.


  • Open Access

    Mutation Spectrum of Hemoglobinopathies in Tunisia

    by Imen Moumni, Khouloud Khalfaoui, Mariem Chebbi, Leila Chaouch, Houyem Ouragini, Dorra Chaouechi, Fethi Mellouli, Monia Ouederni, Monia Benkhaled, Salem Abbes, et al.

    Introduction: Hemoglobinopathies are the most prevalent recessive disorders worldwide, characterized by wide molecular and clinical heterogeneity. They result from mutations within the alpha‐, beta‐, or delta‐globin gene leading to aberrant expression or protein function. These abnormalities are widely spread throughout the Mediterranean basin. Due to their severity and disabling nature, hemoglobinopathies represent a major public health problem. Mutational screening of abnormal hemoglobins (Hbs) allows the creation of a mutation map, which forms the basis for a potential national prevention program in Tunisia. Methods: A total of 260 Tunisian subjects were investigated using biochemical and molecular analyses to identify defects in the globin genes (HBA, HBB, and HBD). The study is aimed at determining the molecular spectrum of hemoglobinopathies and contributing to the development of a comprehensive Hb mutation map in Tunisia. Results: Twenty‐one β ‐thalassemia mutations and 16 rare Hb variants were reported, affecting the HBA, HBD, and HBB genes. Rare Hb variants were identified and described for the first time among Tunisian patients, including Hb A 2 ‐Babinga (HBD:c.410G>A; delta 136: Gly → Asp, GGT → GAT). Other variants, such as Hb Knossos, Hb Summer Hill, Hb Hope, and Hb Köln, which are uncommon in the Mediterranean region, were also detected. Conclusion: This study provides an updated overview of β ‐thalassemia mutations and rare Hb variants in the Tunisian population. These findings are essential for understanding genetic and clinical diversity, improving the clinical management of hemoglobinopathies, and enhancing public health initiatives.

  • Predictors of Delayed Hemolytic Transfusion Reactions in Children With Beta‐Thalassemia Intermedia: Insight From a Tunisian Reference‐Center Analysis

    by Monia Ben Khaled, Ilhem Ben Fraj, Mohamed Jrad, Samia Rekaya, Aicha Ben Taieb, Ikram Zaiter, Takoua Lamouchi, Ridha Kouki, Houda Kaabi, Hamida Slama, et al.

  • Clinical features and predictors of osteoarticular manifestations in common variable immunodeficiency

    by Monia Ben Khaled, Amani Merdassi, Samia Rekaya, Ilhem Ben Fraj, Takwa Lamouchi, Ikram Zaiter, Ridha Kouki, Mohamed Bejaoui, Fethi Mellouli, Monia Ouederni

    Introduction This study aimed to assess osteoarticular manifestations in patients with common variable immunodeficiency (CIVD) and to identify the predictive factors. Methods This was a retrospective and prognostic study conducted in the pediatrics: immuno-hematology and stem cell transplantation department, including patients who fit the definition of CVID. A Cox model analysis was used to identify predictive factors. Results A total of 36 patients were enrolled. Osteoarticular involvement was noted in 15 patients (42%) with a cumulative incidence of 90% after a median follow-up of 25 years. Non-infectious manifestations were reported in 14 patients (39%). The cumulative risk of inflammatory or autoimmune osteoarticular etiology was 74%. Well-characterized rheumatic diseases were retained in six patients and unlabeled autoimmune or inflammatory mechanism in five cases. Bone mineral density revealed osteoporosis in six cases leading to a cumulative risk of degenerative complications of 72%. The cumulative incidence of infectious complications was 17%. In multivariate analysis, predictors of osteoarticular complications were low body weight (HR = 8.67, CI: 1.496–50.278, p = 0.01) and hepatomegaly at diagnosis (HR = 6.2, CI: 1.537–25.075, p = 0.01). Reduced CD4 cells rate < 600 cells/mm3 and hepatomegaly were predictors of autoimmune or inflammatory complications, while chronic diarrhea and iron deficiency were associated with degenerative manifestations. Conclusions Osteoarticular manifestations have emerged as a real health problem for CVID patients. Risk increases with low body weight, hepatomegaly, chronic diarrhea, iron deficiency, and CD4 cells rate under 600 cell/mm3. Elucidating the mechanisms of these complications in CVID is important for developing preventive strategies. Key Points • This retrospective and prognostic study described the clinical characteristics of osteoarticular manifestations in 36 patients with CVID to ensure better recognition and understanding of this association by clinicians. • Identification of predictive factors of osteoarticular complications according to its etiology is crucial to establish appropriate, optimal and early management of patients at risk.


  • Open Access

    CUTANEOUS MANIFESTATIONS OF PRIMARY IMMUNODEFICIENCY DISEASES IN TUNISIAN CHILDREN

    by Naouel Guirat, Monia Ben Khaled, Monia Ouederni, Imen Ben-Mustapha, Ridha Kouki, Habib Besbes, Mohamed Ridha Barbouche, Fethi Mellouli, Mohamed Bejaoui

    Skin manifestations are frequent among patients with primary immunodeficiency diseases (PIDs). Their prevalence varies according to the type of immunodeficiency. This review provides the reader with an up-to-date summary of the common dermatologic manifestations of PIDs among Tunisian children. We conducted a prospective study on two hundred and ninety children with immune deficiency. Demographic details (including age, sex, and consanguinity) with personal and family history were recorded. Special attention was paid to cutaneous manifestations. Dermatological involvements were grouped according to the etiology of their most prominent sign. Cutaneous manifestations were found in 164 patients (56.5%). They revealed the diagnosis of PIDs in 71 patients (24.5 %). The mean age at presentation was 21 months. Overall the most prominent cutaneous alterations were infectious. They accounted for 106 cases (36.55%). The most prevalent causes of cutaneous infections were bacterial: 93 cases (32.06%). Immuno-allergic skin diseases were among the common findings in our study. These include eczematous dermatitis found in 62 cases (21.38%). Malignancy related PIDs was seen in a boy with Wiskott Aldrich syndrome. He developed Kaposi’s sarcoma at the age of 14 months. Cutaneous changes are common among children with PIDs. In pediatric patients with failure to thrive, chronic refractory systemic manifestations often present in other family members, recurrent cutaneous infections unresponsive to adequate therapy, atypical forms of eczematous dermatitis or unusual features should arouse the suspicion of PIDs and prompt specialized immunologic consultation should be made.